Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations

International Journal of Antimicrobial Agents

Volumn 33, Issue 4, 2009, Pages 334-338

  Perdigão, João ^a   Macedo, Rita ^b   Ribeiro, Ana ^a   Brum, Laura ^b   Portugal, Isabel ^a  

^a Lab de Quim Orgânica   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

embB; Ethambutol; Resistance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; GENETIC IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANTITUBERCULAR AGENTS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PENTOSYLTRANSFERASES; PLASMIDS; TUBERCULOSIS;

EID: 61449095498     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.09.021     Document Type: Article

References (22)

1. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Geneva, Switzerland: WHO; 2003.
2. Mikusova K., Slayden R.A., Besra G.S., and Brennan P.J. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 39 (1995) 2484-2489
3. Alcaide F., Pfyffer G.E., and Telenti A. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 41 (1997) 2270-2273
4. Parsons L.M., Salfinger M., Clobridge A., Dormandy J., Mirabello L., Polletta V.L., et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 49 (2005) 2218-2225
5. Ramaswamy S.V., Amin A.G., Göksel S., Stager C.E., Dou S.J., El Sahly H., et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44 (2000) 326-336
6. Berg S., Starbuck J., Torrelles J.B., Vissa V.D., Crick D.C., Chatterjee D., et al. Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan. J Biol Chem 280 (2005) 5651-5663
7. Escuyer V.E., Lety M.A., Torrelles J.B., Khoo K.H., Tang J.B., Rithner C.D., et al. The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J Biol Chem 276 (2001) 48854-48862
8. Zhang N., Torrelles J.B., McNeil M.R., Escuyer V.E., Khoo K.H., Brennan P.J., et al. The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol Microbiol 50 (2003) 69-76
9. Lee A.S.G., Othman S.N.K., Ho Y.M., and Wong S.Y. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 48 (2004) 4447-4449
10. Plinke C., Rusch-Gerdes S., and Niemann S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 50 (2006) 1900-1902
11. Sugawara I., Otomo K., Yamada H., Wang G., Du C., Shi R., et al. The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China. Jpn J Infect Dis 58 (2005) 393-395
12. Telenti A., Philipp W.J., Sreevatsan S., Bernasconi C., Stockbauer K.E., Wieles B., et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3 (1997) 567-570
13. Sreevatsan S., Stockbauer K.E., Pan X., Kreiswirth B.N., Moghazeh S.L., Jacobs Jr. W.R., et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 41 (1997) 1677-1681
14. Hazbón M.H., Bobadilla del Valle M., Guerrero M.I., Varma-Basil M., Filliol I., Cavatore M., et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 49 (2005) 3794-3802
15. Blokpoel M.C.J., Murphy H.N., O'Toole R., Wiles S., Runn E.S.C., Stewart G.R., et al. Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res 33 (2005) e22
16. Parish T., and Stoker N.G. Mycobacteria protocols (1998), Humana Press, Totowa, NJ
17. Perdigão J., Macedo R., João I., Fernandes E., Brum L., and Portugal I. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. Microb Drug Resist 14 (2008) 133-143
18. Johnson R., Jordaan A.M., Pretorius L., Engelke E., van der Spuy G., Kewley C., et al. Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 10 (2006) 68-73
19. Coll P. Drugs with activity against Mycobacterium tuberculosis. Enferm Infecc Microbiol Clin 21 (2003) 299-308 [in Spanish]
20. Shi R., Zhang J., Otomo K., Zhang G., and Sugawara I. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China. Antimicrob Agents Chemother 51 (2007) 4515-4517
21. Lety M.A., Nair S., Berche P., and Escuyer V. A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 41 (1997) 2629-2633
22. Safi H., Sayers B., Hazbón M.H., and Alland D. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 52 (2008) 2027-2034